JPRN-UMIN000001886
Completed
未知
A multicenter observational study of clinical relevance of microalbuminuria and intra-renal RAS in type 2 diabetes. - Clinical relevance of diabetic complications and intra-renal RAS in type 2 diabetes.
Kagawa University, Faculty of Medicine0 sites300 target enrollmentApril 14, 2009
ConditionsType 2 Diabetes Mellitus
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Type 2 Diabetes Mellitus
- Sponsor
- Kagawa University, Faculty of Medicine
- Enrollment
- 300
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Type 1 diabetes mellitus 2\) Pregnancy 3\) Severe renal disease (Proteinuria, CCr\<50 mL/min, sCr \>\= 1\.5 mg/dL) 4\) Severe hepatic disease (GOT \>\= 150 IU or GPT \>\= 150 IU) 5\) Endocrine disease 6\) Patients with malignant tumor 7\) Patients inadequate for the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Multi-center observational study to investigate the effect of immune checkpoint inhibitors on MSI-H/dMMR solid tumorsMSI-H/dMMR solid tumorJPRN-UMIN000044728ational Cancer Center200
Completed
Not Applicable
A multi-center retrospective observational study in patients with relapsed and refractory multiple myeloma receiving once-weekly carfilzomib dosing in combination with dexamethasone in a real-world setting in Japan (Weekly-CAR study)Multiple myelomaJPRN-UMIN000043049Ono Pharmaceutical Co., Ltd.150
Completed
Phase 4
A prospective, observational, multi-centre study investigating alterations of gut microbiome with its subsequent interaction on the brain-immune-intestine axis in patients with active relapsing remitting Multiple Sclerosis who start with oral treatment.multiple sclerosis10029305NL-OMON54765Sint Elisabeth Ziekenhuis72
Recruiting
Not Applicable
A multi-center retrospective observational study of effectiveness, safety and treatment status of tirabrutinib in relapsed or refractory pcnsl (ROSETTA)Relapsed or refractory Primary CNS LymphomaPrimary CNS lymphomaD008228JPRN-jRCT1021230006agane Motoo206
Completed
Not Applicable
A multicenter retrospective observational study evaluating the safety and efficacy of immune checkpoint inhibitors in patients with advanced or recurrent lung cancer after COVID-19 vaccination (NEJ061)advanced or recurrent lung cancerJPRN-UMIN000048096Specified Nonprofit Corporation North East Japan Study Group850